Alven Capital is an independent venture capital fund that manages €150 million, mainly for institutional investors. Alven Capital invests in high-growth companies in the media, services and information-technology sectors. Alven Capital has already invested in more than 40 businesses in Europe, including Companeo, MeilleursAgents.com, SeLoger.com, Newsweb/Boursier.com, Aquarelle, MonShowroom, Liligo, Splendia, Plantes-et-jardins, Wanimo, eBoutich, myfab, Planetveo, Mobile Tag, Qosmos, Webhelp, Prowebce, etc.
Investors
Qosmos is a privately held company backed by venture capital firm Sofinnova Partners, private equity firm Alven Capital, and the GfK Group, one of the world’s largest market research companies.
Alven Capital
GFK
The GfK Group is one of the largest market research companies in the world. The Group has a staff complement of 10,000+ employees working in 150 operating companies covering more than 100 countries of the world who deliver the knowledge on markets and sectors which our clients need for their decisions. The GfK Group is headquartered in Nuremberg, Germany.
GfK is a full-service institute, which regards itself as a supplier of knowledge. It is a company with a tradition, which places a high value on continuity, long-term client relationships and consistent achievement at the highest level. This is also the reason why GfK cultivates its roots, which lie in academic research. The focus on innovation and progress is a central component of GfK’s corporate culture, ensuring that the advanced technology and consistent quality of the methods, tools and practice areas used.
GfK delivers services in all major consumer, pharmaceutical, media and service sector market segments. Services are divided into three sectors: Custom Research, Retail and Technology and Media, a structure based on the sources of the data supplied by GfK to its clients.
Sofinnova Partners
Sofinnova Partners is an independent venture capital firm based in Paris, France. For over 35 years, the firm has backed nearly 500 companies at different stages of development – pure creations, spin-offs, as well as turnaround situations – and worked alongside Europe’s key entrepreneurs in the technology, life sciences and cleantech sectors. With more than €1 billion of funds under management, Sofinnova Partners’ experienced team and hands-on approach in nurturing and supporting portfolio companies through to exit have created market leaders and multiplied revenues, from landmark historical investments including Genentech and Biogen to more recent successes such as Actelion, Vistaprint and CoreValve. With a global mindset, the firm has offices in Shanghai, China and a sister organization in San Francisco, California. Please visit www.sofinnova.fr for more information on Sofinnova’s team and portfolio.
